MYOM2 and neoplasm: Moreover, the proportion of malignant cells in each tumour from our scRNA-seq data correlated strongly with initial M-protein measurements (R = 0.890, P = 7.401e−07, Supplementary Fig. 1h), supporting our use of this marker to define disease progression.